KOSDAQ-Listed Union Korea Pharm Issues Paid-In Capital Increase... Third-Party Allotment to Bukwang Pharmaceutical
Union Korea Pharm, a KOSDAQ-listed company, announced on the 18th that it has decided to issue new shares through a third-party allotment paid-in capital increase.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
A total of 60 million new common shares will be issued at 500 won per share. The third-party allotment recipient is Bukwang Pharmaceutical Co., Ltd. (60 million shares).
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
